Method of treating fibrproliferative disorders
AssigneeZymoGenetics, Inc.
InventorsCharles E. Hart, Stavros Topouzis, Debra G. Gilbertson
Life of this patent
Estimating the term…
Abstract
Materials and Methods for reducing cell proliferation or extracellular matrix production in a mammal are disclosed. The methods comprise administering to a mammal a composition comprising a therapeutically effective amount of a zvegf4 antagonist in combination with a pharmaceutically acceptable delivery vehicle. Exemplary zvegf4 antagonists include anti-zvegf4 antibodies, inhibitory polynucleotides, inhibitors of zvegf4 activation, and mitogenically inactive, receptor-binding variants of zvegf4. The materials and methods are useful in the treatment of, inter alia, fibroproliferative disorders of the kidney, liver, and bone.
Claims4
A method of reducing proliferation of prostate tumor cells which have metastasized to bone in a mammal, wherein the prostate tumor cells express zvegf4, the method comprising administering to the mammal a composition comprising a therapeutically effective amount of a zvegf4 antagonist in combination with a pharmaceutically acceptable delivery vehicle, wherein the antagonist is an antibody that binds to an epitope of a zvegf4 protein as shown in SEQ ID NO:2 from amino acid residue 258 to amino acid residue 370, and inhibits the binding of zvegf4 to PDGF receptor.
Dependencies are inferred from the claim text.